In today’s life sciences landscape, having the right strategy and science is no longer enough. According to Harry Georgiades, Managing Director at IPM, what truly differentiates leading biopharma organizations is their ability to execute—turning strategy into actionable plans and delivering results across the entire product lifecycle.
As teams are pushed to move faster while maintaining quality and compliance, success depends on aligning process, governance, and execution capabilities. Speed and compliance are not mutually exclusive; when quality is built into processes and supported by strong governance, teams can move quickly without missteps.
Looking ahead, adaptability is critical. Investing in operating models that align people, process, and technology enables organizations to translate strategy quickly, manage risk effectively, and adapt to changes in markets and science.
The editorial staff had no role in this post's creation.